Literature DB >> 22911023

Cancer survival in Eastern and Western Germany after the fall of the iron curtain.

Lina Jansen1, Adam Gondos, Andrea Eberle, Katharina Emrich, Bernd Holleczek, Alexander Katalinic, Hermann Brenner.   

Abstract

Prior to the German reunification, cancer survival was much lower in East than in West Germany. We compare cancer survival between Eastern and Western Germany in the early twenty-first century, i.e. the second decade after the German reunification. Using data from 11 population-based cancer registries covering a population of 33 million people, 5-year age-standardized relative survival for the time period 2002-2006 was estimated for the 25 most common cancers using model-based period analysis. In 2002-2006, 5-year relative survival was very similar for most cancers, with differences below 3% units for 20 of 25 cancer sites. Larger, statistically significant survival advantages were seen for oral cavity, oesophagus, and gallbladder cancer and skin melanoma in the West and for leukemia in the East. Our study shows that within two decades after the assimilation of political and health care systems, the former major survival gap of cancer patients in Eastern Germany has been essentially overcome. This result is encouraging as it suggests that, even though economic conditions have remained difficult in Eastern Germany, comparable health care provision may nevertheless enable comparable levels of cancer survival within a relatively short period of time.

Entities:  

Mesh:

Year:  2012        PMID: 22911023     DOI: 10.1007/s10654-012-9723-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  16 in total

1.  Social epidemiology after the German reunification: East vs. West or poor vs. rich?

Authors:  Oliver Razum; Thomas Altenhöner; Jürgen Breckenkamp; Sven Voigtländer
Journal:  Int J Public Health       Date:  2008       Impact factor: 3.380

2.  Socioeconomic inequalities in cancer survival in England after the NHS cancer plan.

Authors:  B Rachet; L Ellis; C Maringe; T Chu; U Nur; M Quaresma; A Shah; S Walters; L Woods; D Forman; M P Coleman
Journal:  Br J Cancer       Date:  2010-06-29       Impact factor: 7.640

3.  Up-to-date long-term survival curves of patients with cancer by period analysis.

Authors:  Hermann Brenner; Timo Hakulinen
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  Socio-economic factors and breast cancer survival--a population-based cohort study (Sweden).

Authors:  Magdalena Lagerlund; Rino Bellocco; Per Karlsson; Göran Tejler; Mats Lambe
Journal:  Cancer Causes Control       Date:  2005-05       Impact factor: 2.506

5.  Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.

Authors:  Hermann Brenner; Bengt Söderman; Timo Hakulinen
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

Review 6.  Socioeconomic differences in cancer survival: a review of the evidence.

Authors:  M Kogevinas; M Porta
Journal:  IARC Sci Publ       Date:  1997

7.  Up-to-date and precise estimates of cancer patient survival: model-based period analysis.

Authors:  Hermann Brenner; Timo Hakulinen
Journal:  Am J Epidemiol       Date:  2006-07-13       Impact factor: 4.897

8.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Authors:  Arduino Verdecchia; Silvia Francisci; Hermann Brenner; Gemma Gatta; Andrea Micheli; Lucia Mangone; Ian Kunkler
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

9.  Standard cancer patient population for age standardising survival ratios.

Authors:  Isabella Corazziari; Mike Quinn; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2004-10       Impact factor: 9.162

10.  Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.

Authors:  M P Coleman; B Rachet; L M Woods; E Mitry; M Riga; N Cooper; M J Quinn; H Brenner; J Estève
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

View more
  5 in total

1.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

2.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

3.  Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.

Authors:  Olaf Schoffer; Stefanie Schülein; Gerlinde Arand; Hans Arnholdt; Dieter Baaske; Ralf C Bargou; Nikolaus Becker; Matthias W Beckmann; Yves Bodack; Beatrix Böhme; Tayfun Bozkurt; Regine Breitsprecher; Andre Buchali; Elke Burger; Ulrike Burger; Klaus Dommisch; Gudrun Elsner; Karin Fernschild; Ulrike Flintzer; Uwe Funke; Michael Gerken; Hubert Göbel; Norbert Grobe; Vera Gumpp; Lucie Heinzerling; Lana Raffaela Kempfer; Alexander Kiani; Monika Klinkhammer-Schalke; Sabine Klöcking; Ute Kreibich; Katrin Knabner; Peter Kuhn; Stine Lutze; Uwe Mäder; Tanja Maisel; Jan Maschke; Martin Middeke; Andreas Neubauer; Antje Niedostatek; Anabelle Opazo-Saez; Christoph Peters; Beatrice Schell; Gerhard Schenkirsch; Harald Schmalenberg; Peter Schmidt; Constanze Schneider; Birgit Schubotz; Anika Seide; Paul Strecker; Sabine Taubenheim; Matthias Wackes; Steffen Weiß; Claudia Welke; Carmen Werner; Christian Wittekind; Jörg Wulff; Heike Zettl; Stefanie J Klug
Journal:  BMC Cancer       Date:  2016-12-05       Impact factor: 4.430

4.  Cancer mortality in former East and West Germany: a story of unification?

Authors:  Daniel Medenwald; Dirk Vordermark; Christian T Dietzel
Journal:  BMC Cancer       Date:  2017-02-02       Impact factor: 4.430

5.  Load and failure behavior of human muscle samples in the context of proximal femur replacement.

Authors:  Stefan Schleifenbaum; Michael Schmidt; Robert Möbius; Thomas Wolfskämpf; Christian Schröder; Ronny Grunert; Niels Hammer; Torsten Prietzel
Journal:  BMC Musculoskelet Disord       Date:  2016-04-06       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.